3-[2-[4-[2-(3,5-ditert-butyl-4-methoxyphenyl)-1,3-thiazol-5-yl]piperidin-1-yl]-2-oxoethyl]-1H-imidazol-2-one
C28H38N4O3S — CID 59571522
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[2-[4-[2-(3,5-ditert-butyl-4-methoxyphenyl)-1,3-thiazol-5-yl]piperidin-1-yl]-2-oxoethyl]-1H-imidazol-2-one
3-[2-[4-[2-(3,5-ditert-butyl-4-methoxyphenyl)-1,3-thiazol-5-yl]piperidin-1-yl]-2-oxoethyl]-1H-imidazol-2-one (PubChem CID 59571522) has the molecular formula C28H38N4O3S and a molecular weight of 510.70 g/mol. Its IUPAC name is 3-[2-[4-[2-(3,5-ditert-butyl-4-methoxyphenyl)-1,3-thiazol-5-yl]piperidin-1-yl]-2-oxoethyl]-1H-imidazol-2-one.
Molecular Properties
| Compound Name | 3-[2-[4-[2-(3,5-ditert-butyl-4-methoxyphenyl)-1,3-thiazol-5-yl]piperidin-1-yl]-2-oxoethyl]-1H-imidazol-2-one |
|---|---|
| PubChem CID | 59571522 |
| Molecular Formula | C28H38N4O3S |
| Molecular Weight | 510.70 g/mol |
| Exact Mass | 510.27 |
| IUPAC Name | 3-[2-[4-[2-(3,5-ditert-butyl-4-methoxyphenyl)-1,3-thiazol-5-yl]piperidin-1-yl]-2-oxoethyl]-1H-imidazol-2-one |
| SMILES | COc1c(C(C)(C)C)cc(-c2ncc(C3CCN(C(=O)Cn4cc[nH]c4=O)CC3)s2)cc1C(C)(C)C |
| InChI | InChI=1S/C28H38N4O3S/c1-27(2,3)20-14-19(15-21(24(20)35-7)28(4,5)6)25-30-16-22(36-25)18-8-11-31(12-9-18)23(33)17-32-13-10-29-26(32)34/h10,13-16,18H,8-9,11-12,17H2,1-7H3,(H,29,34) |
| InChIKey | AYJPMGBOYBXKCK-UHFFFAOYSA-N |
| XLogP | 5.31 |
| TPSA | 80.22 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 510.70 |
| LogP ≤ 5 | 5.31 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 59571522 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.